Jason N Berman

Summary

Affiliation: Nova Scotia
Country: Canada

Publications

  1. ncbi JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I
    Jason N Berman
    Dalhousie Cancer Genetics Research Group, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatr Blood Cancer 51:689-91. 2008
  2. ncbi Using MS-MLPA as an efficient screening tool for detecting 9p21 abnormalities in pediatric acute lymphoblastic leukemia
    R Brett Gardiner
    Department of Microbiology and Immunology, IWK Health Centre Dalhousie University, Halifax, NS, Canada
    Pediatr Blood Cancer 58:852-9. 2012

Collaborators

  • R Brett Gardiner
  • Conrad V Fernandez
  • Christie Riddell
  • Barbara A Morash
  • Hao Wang
  • Margaret Yhap

Detail Information

Publications2

  1. ncbi JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I
    Jason N Berman
    Dalhousie Cancer Genetics Research Group, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
    Pediatr Blood Cancer 51:689-91. 2008
    ..Neurofibromin sequencing failed to identify a causative mutation. An unknown genetic abnormality resulting in NF1 may have predisposed this young child to acquiring the common JAK2 mutation...
  2. ncbi Using MS-MLPA as an efficient screening tool for detecting 9p21 abnormalities in pediatric acute lymphoblastic leukemia
    R Brett Gardiner
    Department of Microbiology and Immunology, IWK Health Centre Dalhousie University, Halifax, NS, Canada
    Pediatr Blood Cancer 58:852-9. 2012
    ..The incidence of 9p21 using more sensitive techniques, such as methylation specific multiplex ligation-dependent probe amplification (MS-MLPA), remains uncertain, and thus also the prognostic significance...